Hyaluronic Acid in Shoulder Tendinopathy
ConditionShoulder Tendinitis
Trial statusRecruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexAll
Age18-65
SponsorCentre Hospitalier Departemental Vendee
About this trial
Multicentric, randomised study to compare the effectiveness on activity pain at 3 months of corticosteroid injection associated with hyaluronic acid with corticosteroids injection alone in patients with tendinopathy of the supraspinatus with clinical reevaluation at one, three and six months.
Eligibility criteria
Qualifiers
Active patient aged between 18 and 65;
Patient suffering from pain compatible with supraspinatus tendinopathy for at least 2 months;
Patient with simple tendinopathy or partial tendon rupture;
Patient with tendinopathy confirmed by ultrasound or MRI;
Disqualifiers
Patient suffering from a transfixing tendon rupture;
Patients suffering from post-traumatic tendon rupture;
Patients suffering from calcific tendinopathy (calcification > 5 mm);
Patients with associated glenohumeral osteoarthritis;
Trial design
Treatments tested in this trial
- Hyaluronic acid injection
- Corticosteroid injection
- Placebo injection
Treatment groups
132 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov